Epoetin beta

Epoetin beta
Clinical data
Pronunciation	/ɛˈpoʊ.ɪtɪn/
Trade names	Neorecormon, Betapoietin, others
AHFS/Drugs.com	International Drug Names
License data	EU EMA: by INN;
Pregnancy; category	AU: B3;
Routes of; administration	Intravenous, subcutaneous
ATC code	B03XA01 (WHO) ;
Legal status
Legal status	AU: S4 (Prescription only); EU: Rx-only; In general: ℞ (Prescription only);
Identifiers
CAS Number	122312-54-3 ;
DrugBank	DB00016 ;
ChemSpider	none;
UNII	64FS3BFH5W;
KEGG	D03232 ;
	(what is this?) (verify)

Epoetin beta (INN), sold under the brand name Neorecormon among others, is a synthetic, recombinant form of erythropoietin, a protein that promotes the production of red blood cells. It is an erythropoiesis-stimulating agent (ESA) that is used to treat anemia, commonly associated with chronic kidney failure and cancer chemotherapy.